Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Thermo Fisher Scientific

How Is Thermo Fisher Scientific’s Stock Performance Compared to Other Medical Devices Stocks?

While Thermo Fisher Scientific has underperformed the broader medical device industry recently, analysts remain optimistic about the company's future outlook.

Nasdaq Futures Fall on Higher Bond Yields Ahead of Tesla Earnings

Nasdaq Futures Fall on Higher Bond Yields Ahead of Tesla Earnings

December Nasdaq 100 E-Mini futures (NQZ24) are trending down -0.23% this morning as Treasury yields continued to rise on the prospect of less aggressive Federal Reserve interest rate cuts, while investors awaited a slew of corporate earnings reports, with a particular focus on results from “Magnificent Seven” member Tesla.

Thermo Fisher Scientific's Q3 2024 Earnings: What to Expect

Thermo Fisher Scientific's Q3 2024 Earnings: What to Expect

Thermo Fisher Scientific is poised to release its third-quarter results later this month, and analysts expect a single-digit earnings dip.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Thermo Fisher Scientific Stock: Is TMO Underperforming the Healthcare Sector?

Thermo Fisher Scientific recently underperformed the healthcare sector, but Wall Street analysts are bullish about the stock’s prospects.

Thermo Fisher Scientific Stock: Analyst Estimates & Ratings

Thermo Fisher Scientific has underperformed relative to the broader market over the past year, yet analysts are bullish on the stock's potential.

GOP candidate pushed "surveillance" tech

After leaving Congress, Reichert took up work as a lobbyist, urging foreign governments to adopt "Rapid DNA"

Is Thermo Fisher Scientific Stock Underperforming the Dow?

Although Thermo Fisher Scientific underperformed the Dow Jones Industrial Average over the past year, analysts remain optimistic about the company's future due to its increasing demand and strategic product launches.

inkl

Read news from The Economist, FT, and more,
with one subscription

Thermo Fisher Scientific and C-CAMP announce collaborative initiative to establish centre of excellence in Bengaluru

Thermo Fisher Scientific and C-CAMP announce collaborative initiative to establish centre of excellence in Bengaluru

Thermo Fisher Scientific and the Centre for Cellular and Molecular Platforms (C-CAMP) recently announced a collaborative initiative to establish a Centre of Excellence in Bengaluru. This state-of-the-art facility will serve as a hub for fostering innovation, accelerating breakthroughs in the biotechnology sector and enabling researchers to enhance their expertise and…

Bear Put Spread Screener Results For September 20th

Bear Put Spread Screener Results For September 20th

With volatility at the lowest levels in two years, options are cheap so it’s a good time to check in on our bear put spread screener.

Settlement with family of Henrietta Lacks is an opportunity to reflect on inequalities in genetic research

Settlement with family of Henrietta Lacks is an opportunity to reflect on inequalities in genetic research

Aug. 1, 2023 would have been Henrietta Lacks’s 103rd birthday. It was also the day the Lacks family reached a settlement with Thermo Fisher Scientific, the biotech company that used and profited from her “HeLa” cells.

The Conversation

First Thing: Donald Trump faces four charges over efforts to overturn 2020 election

First Thing: Donald Trump faces four charges over efforts to overturn 2020 election

Latest criminal case before ex-president has come weeks after he was charged with retaining national defense information. Plus, experts warn of record US deaths from extreme heat

The Guardian - UK

Immortal cells: Henrietta Lacks’ family settle lawsuit over HeLa tissue harvested in 1950s

Immortal cells: Henrietta Lacks’ family settle lawsuit over HeLa tissue harvested in 1950s

Cells taken without consent from cancer victim can reproduce indefinitely and were sold for unjust profit by Thermo Fisher Scientific, relatives argued

The Guardian - AU

Biotech company settles lawsuit for profiting off of woman’s cloned cells for seven decades

Biotech company settles lawsuit for profiting off of woman’s cloned cells for seven decades

Henrietta Lacks’ unique ‘Hela’ cells played a crucial role in the development of Covid-19 vaccines and treatments for HIV, leukemia and cancer

The Independent UK

Henrietta Lacks' descendants reach a settlement over the use of her 'stolen' cells

Henrietta Lacks' descendants reach a settlement over the use of her 'stolen' cells

Her genetic material, taken without her knowledge in 1951, has helped facilitate numerous scientific breakthroughs, including the development of the polio and COVID-19 vaccines.

Get all your
news in one place.

100's of premium titles.
One news app.

How 9 companies are preparing for the A.I. talent battle

Companies like Salesforce and Coca-Cola are competing to hire and train the best A.I. talent.

Stocks Climb Before the Open as Strong Big Tech Earnings Overshadow Recession Worries

June S&P 500 futures (ESM23) are up +0.40%, and June Nasdaq 100 E-Mini futures (NQM23) are up +1.27% this morning as solid earnings from a couple of U.S. tech giants boosted market sentiment.

1 2

People

204,303 stories

Christine Lagarde

Henrietta Lacks

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

British Airways

Microsoft Corporation

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Corporate Earnings

Places

400,907 stories

Central America

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play